Hypothesis driven, innovative basic (T0-discovery) research that will improve our understanding of the underlying mechanisms of childhood cancer and identify novel, safe and effective new treatment strategies and technologies that will have the potential to translate to patient benefit in the clinic.
The strategic priority is to support innovative discovery research that will improve the understanding of underlying mechanism of disease and identify novel, safe and effective new treatments.